|
Market Cap (9-Jul) $423,290,624 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (19-Jun) 1,217,772 (1.50%) (163rd) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 16 April 2021, 8:24. The announcement is marked as price sensitive, and is 3 page(s) in length and 123.85kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 1.542% short sold according to ASIC data. It was ranked the 129th most shorted stock on the ASX. It remains ranked 163rd as of the latest reported data (19 June 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| FDA approval of novel oral contraceptive NEXTSTELLIS | 16 April 2021, 8:24 |
| Appendix 3G | 19 March 2021, 12:39 |
| New data on NEXTSTELLIS presented at ISSWSH conference | 8 March 2021, 9:10 |
| Change in substantial holding | 5 March 2021, 16:00 |
You must be logged in to post a reply.
Mayne Pharma Group 